retatrutide phase 2 results weight loss trial obesity Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized 2a with retatrutide as – Retatrutide shows substantial weight loss,
Pay in 4 interest-free payments of $5.02 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30


























